Travere Therapeutics, Inc. Stock Forecast
Red day on Thursday for Travere Therapeutics, Inc. stock after losing 1.10%
(Updated on Apr 25, 2024)
The Travere Therapeutics, Inc. stock price fell by -1.10% on the last day (Thursday, 25th Apr 2024) from $5.45 to $5.39. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.42% from a day low at $5.12 to a day high of $5.50. The price has fallen in 9 of the last 10 days and is down by -19.43% for this period. Volume has increased on the last day by 281 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $7.78 million.
The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($5.71) are considered to be a "second chance" to get out. According to the fan-theory $4.32 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TVTX Signals & Forecast
There are few to no technical positive signals at the moment. The Travere Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.71 and $7.05. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -33.37%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.380 between high and low, or 7.42%. For the last week, the stock has had daily average volatility of 6.02%.
Travere Therapeutics, Inc. is oversold on RSI14 (8). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TVTX) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Travere Therapeutics, Inc. to open at $5.34, and during the day (based on 14 day Average True Range), to move between $5.01 and $5.77, which gives a possible trading interval of +/-$0.383 (+/-7.10%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.20% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $5.74, some $0.350 (6.49%) from the current price of $5.39, our system finds the risk reward not very attractive.
Earnings coming up
Travere Therapeutics, Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.95. We will update the financials statements for Travere Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.29% in the first trading day after earnings release.
Is Travere Therapeutics, Inc. stock A Buy?
Travere Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -6.449 Strong Sell Candidate Unchanged
Predicted Opening Price for Travere Therapeutics, Inc. of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $5.34 ( 0.99%) | $5.39 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TVTX
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 5.72 | 6.06 % | |
| R2 | 5.57 | 3.37 % | ||
| R1 | 5.48 | 1.70 % | ||
| Current price: | 5.39 | |||
| Support | S1 | 5.19 | -3.68 % | |
| S2 | 5.10 | -5.35 % | ||
| S3 | 4.96 | -8.04 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 6.67 | 23.75 % | |
| R2 | 5.99 | 11.13 % | ||
| R1 | 5.74 | 6.49 % | ||
| Current price | 5.39 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Travere Therapeutics, Inc. Stock.
